An observational study in Health Related, sponsored by The First Affiliated Hospital of Zhengzhou University. Recruiting at 1 site in China. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2019-06-19.
Sponsored by The First Affiliated Hospital of Zhengzhou University · Observational
The Prospective Cohort Study for PCOS Patients was set up to investigate the short- and long-term health consequences in Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University, China.
Polycystic ovary syndrome (PCOS) affects 8-13% of women. It is a multifaceted condition characterized by chronic anovulation and excess ovarian activity.
Since last decade, Clinical Reproductive Medicine Management System/Electronic Medical Record Cohort Database (CCRM/EMRCD) has been used in Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University, and Henan Province Key Laboratory for Reproduction and Genetics. Information of patients (POI, PCOS, Endometriosis, azoospermia, ect) were recorded comprehensively. The current project plans to recruit PCOS participants in our center. Biological samples, questionnaires and short/long term health data will be collected. The study is aimed to provide evidence for PCOS prognosis.
The First Affiliated Hospital of Zhengzhou University is the lead sponsor of 123 studies on the registry; 72 are open to participants now.
Counted across the registry records on this site, refreshed daily.
PCOS patients diagnosed with The Rotterdam diagnostic criteria.
Exclusion Criteria:
-
Level of serum FSH (Follicle stimulating hormone)
mIU/mL
Time frame: From date of inclusion, assessed by each 12 month, up to 40 years
Level of serum LH (Luteinizing hormone)
mIU/mL
Time frame: From date of inclusion, assessed by each 12 month, up to 40 years
Level of T (Testosterone)
ng/ml
Time frame: From date of inclusion, assessed by each 12 month, up to 40 years
Body Weight
Recorded in Kilograms
Time frame: From date of inclusion, assessed by each 12 month, up to 40 years
Height
Recorded in centimeters
Time frame: From date of inclusion, assessed by each 12 month, up to 40 years
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The First Affiliated Hospital of Zhengzhou University